Anapc13, whose specific function details are yet to be fully elaborated, has been implicated in various biological processes. It has been associated with pathways related to cell proliferation regulation, as well as in some disease-related contexts such as cancer, chronic pancreatitis, and atopic asthma [1,2,4,5]. Animal models like gene-modified mice can be valuable in further exploring its function.

In a study on Treg-specific expression of SF3B1-K700E in mice, SF3B1-K700E induced an aberrant splicing event in Anapc13, reducing its expression. Forced expression of Anapc13 restored the differentiation and function of Tregs in preventing adoptive-transfer colitis, highlighting Anapc13's role in regulating Treg function, which in turn impacts immune responses and cancer development [1]. In breast ductal carcinoma, down-regulation of Anapc13 was an early event in the progression of pre-invasive ductal carcinoma, and its down-regulation was associated with genomic instability in this disease [3].

In conclusion, Anapc13 appears to play a significant role in processes related to immune regulation and cancer progression. The findings from mouse models, especially those related to Treg function and breast cancer progression, contribute to our understanding of the biological functions of Anapc13 and its implications in specific disease areas.